APA (7th ed.) Citation

H, L., F, B., L, C., D, P., Z, C., M, S., . . . W, E. (2026). Targeting APE1-Redox Function Reverses SOX9-mediated Chemoresistance in Esophageal Adenocarcinoma. Gastroenterology, 170(7), 1484. https://doi.org/10.1053/j.gastro.2025.12.019

Chicago Style (17th ed.) Citation

H, Lu, et al. "Targeting APE1-Redox Function Reverses SOX9-mediated Chemoresistance in Esophageal Adenocarcinoma." Gastroenterology 170, no. 7 (2026): 1484. https://doi.org/10.1053/j.gastro.2025.12.019.

MLA (9th ed.) Citation

H, Lu, et al. "Targeting APE1-Redox Function Reverses SOX9-mediated Chemoresistance in Esophageal Adenocarcinoma." Gastroenterology, vol. 170, no. 7, 2026, p. 1484, https://doi.org/10.1053/j.gastro.2025.12.019.